Cello Health PLC (LSE:CLL) - Share price - Overview

Stock Report

Cello Health PLC CLL

Last Price
GBX109.90

Day Change
0.40|0.37%

As of 22/02/2019
12:29:52 GMT | GBX
Minimum 15 Minutes Delay.

Last Close109.50p
Day Range108.66 - 110.00
Mkt Cap114.70Mil
52-Wk Range95.00 - 139.88
Yield %3.14
ISINGB00B0310763
Volume15,535
P/E13.02
P/S0.01
P/CF0.42

Share Price

Total Returns 21/02/2019

 Chg (%)  
More ...
Cello Health PLC5.29 
FTSE 100 TR GBP3.40
 
Financials
201520162017
More ...
Income Statement
Turnover156.74165.27169.29
Operating Profit10.5911.1113.07
Net Profit3.32-2.514.23
Reported EPS3.76-2.864.03
Balance Sheet
Current Assets48.9354.3367.54
Non Current Assets77.5573.9878.07
Total Assets126.48128.30145.61
Current Liabilities44.6849.1949.89
Total Liabilities---
Total Equity70.8266.5582.87
Cash Flow
Operating Cash Flow8.256.514.79
Net Change in Cash-0.481.765.87
Director Dealings
TradedActionNotifierPriceAmountValue
More ...
31/10/2018PurchaseMr. Mark Coleridge Scott113.0010,00011,300.00
09/10/2018PurchaseMr. Christopher Ian Montague Jones132.0022,72629,998.00
25/09/2018PurchaseMr. Clifford Peter Tompsett137.0020,00027,400.00

Company Profile

Cello Health PLC with its subsidiary company provides market research and direct communications services to its consumer. Its segments include Cello Health and Cello Signal.

Sector

Marketing Services

Index

FTSE AIM All-Share

Next Event 21/03/2019

Final Results
Ratios
Comp
More ...
PER (E)24.29
Div Yld (E)3.46
PEG (E)0.00
ROCE6.45
Op Mrgn0.08
EPS Grwth2.48
Dividends
PreviousLatest
More ...
Record Date04/05/1805/10/18
Ex-Div03/05/1804/10/18
Paid25/05/1802/11/18
Amnt2.451.10
Directors
More ...
Executive Director, Finance Director and Company SecretaryMr. Mark Bentley
Executive Director, Chief ExecutiveMr. Mark Coleridge Scott
Executive Director, Group Corporate Development DirectorMr. Stephen Highley
Non-Executive Director, ChairmanMr. Allan Jeffrey Rich
Non-Executive DirectorMr. Paul Richard Hamilton
Non-Executive DirectorMr. William Nigel David
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2019 Morningstar. All rights reserved.